The Palmer Foundation takes on challenge to source a COVID-19 treatment

Our world has been turned upside down. We have the daunting prospect of thousands, or even millions of people being affected by COVID-19. A lot of people have talked about a vaccine, and while a vaccine (which prevents you getting a disease) is vitally important, we have to look at what we can do when people do get the disease.

Despite politicised bad press, the malaria drug hydroxychloroquine has shown enormous promise in the treatment of COVID-19. That’s why The Palmer Foundation has made substantial resources available to fund clinical trials, scale up the availability of hydroxychloroquine, and have enough of the drug available for all Australians, free of charge.

The Palmer Foundation has supplied 30 million doses, which is with the Australian national medical stockpile. 

 

It is important for us to see through the chaff out there. We hope you find these resources valuable. This is a situation that changes every day, and affects everyone. When it comes to life and death, politics and profit should not compete with real world solutions that are affordable to all right now.

Communications from Palmer Foundation and Clive Palmer

11/03/2021
29/04/2020
29/04/2020
28/04/2020
24/04/2020
23/04/2020
11/04/2020
04/04/2020
27/03/2020
24/03/2020
24/03/2020
23/03/2020
18/03/2020

Covid-19 vaccine concerns: Clive Palmer

Australia
blank

Richo and Jones interviews Clive Palmer; thanks him for his generous hydroxychloroquine donation to the nation

Australia
blank

Clive Palmer takes out three-page ads promoting reason he purchased hydroxychloroquine, free for Australians

Announcements
blank

Infographic: The COVID-19 Hydroxychloroquine story

Announcements
blank

Coronavirus Australia: Clive Palmer’s foundation funds 32.9 million doses of hydroxychloroquine

Australia
blank

Palmer buys 32,900,000 doses of Hydroxychloroquine for Australians

Announcements
blank

Background – Important announcement regarding COVID-19

Announcements
blank

Sky News Gold Coast interview

Australia
blank

Palmer Rejects Advice to Reduce Staff

Australia
blank

7 News interview with Clive Palmer on Corona Virus

Australia
blank

Clive Palmer to fund 30 million doses of possible treatment

Australia
blank

Palmer agrees to fund the manufacture or acquisition of over 1,000,000 courses of Hydroxychloroquine for Australians

Australia

Palmer donates $1 million to Royal Brisbane Hospital to fight coronavirus

Australia
On Trend

Popular Stories

blank
Azithromycin

A Conversation With Dr. Brian Tyson – The Chloroquine Wars Part XLI

The data from the vaccine trials must be recalculated under the lens that some of the serious adverse events (SAEs) should be treated as COVID-19 cases.
There may not be any vaccine efficacy in the data at all if some of the post-vaccination deaths are due to vaccine-induced COVID-19. It could even be the case that the mortality efficacy goes negative. My implied lives saved calculations put this easily in the realm of possibility. The only way to know is for authorities to organize and compile the data. And while a risk analysis is certainly due after more than six months of hundreds of millions of doses delivered, there is little indication authorities have bothered with the process. That’s more than a bit unsettling.

Read More »
blank
Hydroxychloroquine

Dr. Brian Tyson, USA: Hydroxychloroquine – Data, Strategies and Success Treating over 6000 Covid Patients

We continue to delve extensively into the COVID-19 data with esteemed statistician, Mathew Crawford. In this episode, we take a closer look at the use of early treatment and its success. Mathew has been researching the data from Dr. Brian Tyson, who has successfully treated over 6000 patients who contracted COVID throughout the pandemic. It is my great honor to have Dr. Tyson here on this episode to not only discuss the data, but also the strategies that he has been using throughout the pandemic.

Read More »